loader
Please Wait
Applying Filters...
menu
    • menu

    FDA Approvals: Bayer’s Adempas (Riociguat) Receives Supplemental Approval in US - Bayer Ag

    MenuBayer Ag

    Uploaded: 2022
    News
    Bayer Completes Acquisition of Perfuse Therapeutics

    17 Jun 2026

    // CONTRACTPHARMA

    Bayer Reshuffles Global Consumer Health Leadership for Growth

    08 Jun 2026

    // BUSINESSWIRE

    Bayer Pursues Wider Label After Kerendia's Non-Diabetic CKD Win

    05 Jun 2026

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    BIO International Convention

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/top-pharma-companies-drugs-in-2025-lilly-vaults-eight-spots-to-emerge-at-the-top-glp-1-drugs-dominate-list
    Xls

    CATEGORY PAGE
    Menu

    Bayer Ag

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100137
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.